3.19

1.24% -0.04

After Hours: 3.17 -0.02 -0.63%

Sensus Healthcare Inc (SRTS)

Overview News Price History Option Chain Financials Discussions Forecast

Sensus Healthcare Inc stock is traded at $3.19, with a volume of 38,049. It is down -1.24% in the last 24 hours and down -21.04% over the past month. Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Previous Close:

$3.23

Open:

$3.23

24h Volume:

38,049

Relative Volume:

0.60

Market Cap:

$52.51M

Revenue:

$22.53M

Net Income/Loss:

$-7.77M

P/E Ratio:

-6.7186

EPS:

-0.4748

Net Cash Flow:

$-740.00K

1W Performance:

-11.63%

1M Performance:

-21.04%

6M Performance:

-20.65%

1Y Performance:

-31.84%

1-Day Range:

$3.16

$3.28

1-Week Range:

$3.10

$3.5824

52-Week Range:

$2.82

$5.92

Sensus Healthcare Inc Stock (SRTS) Company Profile

Name

Sensus Healthcare Inc

Sector

Healthcare (1108)

Industry

Medical Devices (143)

Phone

561-922-5808

Address

851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL

Employee

Twitter

@sensushealth

Next Earnings Date

2026-05-07

Latest SEC Filings

SRTS's Discussions on Twitter

Compare SRTS vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SRTS Sensus Healthcare Inc	3.19	53.17M	22.53M	-7.77M	-740.00K	-0.4748
ABT Abbott Laboratories	87.41	152.88B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	316.48	120.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	78.60	100.34B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.78	84.95B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.78	47.91B	6.30B	1.07B	1.09B	1.8406

Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-06-26	Initiated	Alliance Global Partners	Buy
Jan-31-25	Initiated	Lake Street	Buy
Nov-15-24	Reiterated	Maxim Group	Buy
Feb-26-21	Upgrade	Northland Capital	Market Perform → Outperform
Dec-16-20	Downgrade	Northland Capital	Outperform → Market Perform
Aug-10-20	Upgrade	Alliance Global Partners	Neutral → Buy
Feb-14-20	Upgrade	Alliance Global Partners	Neutral → Buy
Nov-07-19	Downgrade	B. Riley FBR	Buy → Neutral
Jan-29-19	Downgrade	Northland Capital	Market Perform → Under Perform
Sep-26-18	Initiated	B. Riley FBR	Buy
Nov-03-17	Reiterated	Maxim Group	Buy
Jun-06-17	Initiated	Maxim Group	Buy
Aug-08-16	Initiated	Northland Capital	Outperform

View All

Sensus Healthcare Inc Stock (SRTS) Latest News

May 21, 2026

Sensus Healthcare (SRTS) Posts Weak Q1 2026 — Misses on Both Top and Bottom LinesCrowd Stock Picks - Newser

May 21, 2026

May 20, 2026

Sensus Healthcare (SRTS) Q1 2026 Earnings: Miss Sparks ConcernOne-Time Loss Impact - Newser

May 20, 2026

SRTS to Host Virtual Meeting on May 21 - GuruFocus

May 20, 2026

Sensus Healthcare Balances Weak Quarter With Growth Catalysts - TipRanks

May 20, 2026

How The Sensus Healthcare (SRTS) Story Is Shifting With New Targets And 2026 Reimbursement Changes - Yahoo Finance

May 20, 2026

May 17, 2026

Number of shareholders of Sensus Healthcare, Inc. – TRADEGATE:5TX - TradingView

May 17, 2026

May 16, 2026

Sensus Healthcare Q1 earnings call highlights - MSN

May 16, 2026

May 14, 2026

Sensus outlines full year profitability goal for 2026 as new CPT codes take effect - MSN

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 13, 2026

Skin cancer cases rising in the U.S., report says (Video) - Social News XYZ

May 13, 2026

Sensus Healthcare 1Q 2026: Revenue $3.39M, EPS $(0.16) — 10-Q Summary - TradingView

May 13, 2026

Maxim Group Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Maintains Target Price $6 - Moomoo

May 12, 2026

Sensus Healthcare director Eric Sachetta buys $5,002 in stock By Investing.com - Investing.com Nigeria

May 12, 2026

Sensus Healthcare director Eric Sachetta buys $5,002 in stock - Investing.com

May 12, 2026

Sensus Healthcare (SRTS) director Eric Sachetta adds 1,500 shares in open-market buy - Stock Titan

May 12, 2026

May 11, 2026